Scleral depressed vitreous shaving, 360 laser, and perfluoropropane (C3 F8) for retinal detachment.
Scleral depressed vitreous shaving, 360 laser, and perfluoropropane (C3 F8) for retinal detachment.
复制标题
DOI：
10.4103/0301-4738.138621
复制
发表时间：
2014-07
影响因子：
3.1
通讯作者：
Rezaei KA
中科院分区：
文献类型：
--
作者：
Chaturvedi V;Basham RP;Rezaei KA
回顾接受睫状体平坦部玻璃体切除术（PPV）联合巩膜凹陷玻璃体刮除、360度外周眼内激光和14%C3F8气体治疗孔源性视网膜脱离（RRD）的患者的特征和结局。对一系列连续患者进行了回顾性分析，这些患者通过PPV联合巩膜凹陷玻璃体刮除、360度外周眼内激光和14%全氟丙烷（C3 F8）进行了RRD一期修复。随访时间少于3个月、既往接受过视网膜手术和高于B级增生性玻璃体视网膜病变的患者被排除。91只眼纳入研究。平均年龄为60.1岁。平均随访13.7个月。63%（58/91）的患眼发生黄斑脱离。一次手术后的再附着率为95%（86/91），而总体再附着率为100%。上级、鼻/颞或下RRD的再附着率之间没有统计学显著差异。平均最终最佳矫正视力（BCVA）为20/40。在所有患者中，66%的黄斑脱落RRD患者的最终BCVA为20/40或更好。PPV联合巩膜凹陷玻璃体刮除、360度外周眼内激光和14%C3F8导致原发性RRD患者成功解剖复位，视力改善。
To review the characteristics and outcomes of patients who underwent pars plana vitrectomy (PPV) with scleral depressed vitreous shaving, 360 degree peripheral endolaser, and 14% C3F8 gas for rhegmatogenous retinal detachment (RRD). A retrospective review of a consecutive series of patients who underwent primary repair of RRD by PPV with scleral depressed vitreous shaving, 360 degree peripheral endolaser, and 14% perfluoropropane (C3F8) was conducted. Patients with less than 3 months follow-up, previous retinal surgery, and higher than grade B proliferative vitreoretinopathy were excluded. Ninety-one eyes were included in the study. The mean age was 60.1 years. The mean follow-up was 13.7 months. The macula was detached in 63% (58/91) of the eyes. The reattachment rate after one surgical procedure was 95% (86/91) while overall reattachment rate was 100%. There was no statistically significant difference between reattachment rates of superior, nasal/temporal, or inferior RRDs. The mean final best corrected visual acuity (BCVA) was 20/40. Of all the patients, 66% of patients with macula-off RRDs had a final BCVA of 20/40 or better. PPV with scleral depressed vitreous shaving, 360 degree peripheral endolaser, and 14% C3F8 leads to successful anatomical reattachment with visual improvement in patients with primary RRD.